Endoglucanase mutant with improved thermal stability and preparation method thereof
By performing site-directed mutation of endoglucanase, mutants with higher thermal stability and catalytic performance are obtained, solving the problem of low efficiency of existing enzymes under high temperature conditions and achieving high efficiency in a wider temperature range Catalytic performance, suitable for industrial production.
Patent Information
- Application Number
- CN202411305403.7
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- Filing Date
- 2024-09-19
- Publication Date
- 2024-11-08
- Estimated Expiration
- 2044-09-19
AI Technical Summary
The existing endoglucanase has low catalytic efficiency under high temperature conditions, which cannot meet the needs of industrial production, and its thermal stability is insufficient, affecting industrial applications.
By artificial site-directed mutation of endoglucanase derived from Bacillus leucid, three mutants were obtained: V217L, N264Y and R170P/N264Y, which improved the thermal stability and catalytic performance of the enzyme.
After treatment with 95°C, the enzyme activity of the mutant increased by 217%, and maintained good catalytic performance within the temperature range of 65°C to 95°C, which was significantly better than the original enzyme and was suitable for industrial applications.
Smart Images

Figure CN118910015A_ABST
Abstract
Description
Technical Field
[0001] The invention relates to an endoglucanase mutant, in particular to an endoglucanase mutant with improved thermal stability, and belongs to the technical field of genetic engineering. Background Art
[0002] Cellulose is the most widely distributed and abundant polysaccharide in nature. It is an environmentally friendly, biodegradable natural organic polymer material. Cellulose and its derivatives are widely used in many fields such as biomedicine, food, electronic components, and new energy. Its hydrolyzate is an important raw material for brewing engineering, production of paper and textiles, biofuels, and chemicals. As the main structural component of plant cell walls, cellulose is usually combined with hemicellulose, pectin, and lignin, so it has a great influence on the texture of plant-based products. For example, in the food processing industry, the presence of cellulose will reduce the extraction rate and quality of juice, and have a negative impact on production efficiency and product quality. Among the various methods of degrading cellulose, the biodegradation method using cellulase has become the focus of attention in industrial production related to cellulose due to its mild reaction conditions and environmental friendliness.
[0003] Endoglucanase is an important cellulase that can randomly cut the amorphous region inside the cellulose polysaccharide chain, hydrolyze glycosidic bonds, break cellulose chains, produce oligosaccharides of different lengths and the ends of new chains, and play an important role in degrading cellulose molecules. The enzymatic properties of endoglucanases from different sources vary greatly. The currently known endoglucanases have low catalytic efficiency under high temperature conditions and cannot meet the needs of industrial production. Chinese invention patent CN 108048430A discloses an endoglucanase NfEG12A mutant and its encoding gene and application, the optimum temperature of the mutant is 65°C, and the catalytic efficiency at this temperature is 0.5 to 0.8 times higher than that of the wild enzyme. Chinese invention patent CN 102443576A discloses an endoglucanase mutant and its encoding gene and application, the mutant has a wide working temperature range, the optimum temperature is 75°C and the specific activity at this temperature is higher than that of the wild type. Endoglucanases with higher thermal stability can maintain more efficient catalytic performance in complex environments of practical applications. Summary of the invention
[0004] Purpose of the invention: The purpose of the present invention is to provide an endoglucanase mutant with improved thermal stability, and to provide a nucleic acid molecule encoding the mutant, a vector or recombinant cell or product comprising the mutant, and a preparation method and application of the mutant.
[0005] Technical solution: The first aspect of the present invention provides three endoglucanase mutants, wherein the amino acid sequence of the endoglucanase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, and the mutation is V217L or N264Y or R170P / N264Y.
[0006] The present invention uses endoglucanase from Geobacillus sp. 70PC53 as the original enzyme, whose amino acid sequence is shown in SEQ ID No. 1, and nucleotide sequence is shown in SEQ ID No. 2. The endoglucanase mutant is obtained by artificially performing site-directed mutation on the original enzyme.
[0007] The present invention uses the standard single letter and standard substitution notation of amino acids: V217L means that the valine (V) at the 217th position of the N-terminus is mutated to leucine (L); R170P / N264Y means that the arginine (R) at the 170th position of the N-terminus is mutated to proline (P), and the asparagine (N) at the 264th position of the N-terminus is mutated to tyrosine (Y).
[0008] In a second aspect, the present invention provides a nucleic acid molecule encoding the endoglucanase mutant described in the first aspect. The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.2.
[0009] In a third aspect, the present invention provides a vector comprising the nucleotide sequence described in the second aspect. The vector may be a cloning vector or an expression vector.
[0010] In a fourth aspect, the present invention provides a recombinant cell, wherein the recombinant cell comprises the vector described in the third aspect.
[0011] In a fifth aspect, the present invention provides a method for preparing the endoglucanase mutant described in the first aspect, comprising the following steps: (1) designing point mutation primers, using a plasmid containing the nucleotide sequence of SEQ ID NO.2 as a template, performing a PCR reaction, digesting the template with an endonuclease, and then recombining the digestion product to obtain an expression vector carrying a mutant gene; (2) transferring the expression vector into a host bacterium for fermentation expression; and (3) collecting the broken cells of the host bacterium, centrifuging and taking the supernatant to obtain the endoglucanase mutant.
[0012] In a sixth aspect, the present invention provides a product, comprising the endoglucanase mutant described in the first aspect, or the nucleic acid molecule described in the second aspect, or the vector described in the third aspect, or the recombinant cell described in the fourth aspect.
[0013] In a seventh aspect, the present invention provides a use of the product described in the sixth aspect in catalyzing cellulose hydrolysis, wherein the catalytic temperature is 65°C to 95°C.
[0014] Beneficial effects: Compared with the prior art, the present invention has the following significant advantages: 1. The thermal stability of the endoglucanase mutant provided by the present invention is better than that of the original enzyme. After being treated at 95°C, the residual enzyme activity of the mutant can be increased by 217% compared with the original enzyme; 2. The relative enzyme activity of the endoglucanase mutant provided by the present invention within the range of 65°C to 95°C is higher than that of the original enzyme, and it can maintain good catalytic performance within a higher and wider temperature range, and has good industrial application prospects. BRIEF DESCRIPTION OF THE DRAWINGS
[0015] Figure 1 Schematic diagram of the protein structure of the original enzyme of the present invention (including amino acid position No. 217);
[0016] Figure 2 The schematic diagram of the protein structure of the original enzyme of the present invention (including the 170th and 264th amino acid sites);
[0017] Figure 3 Schematic diagram of the relative enzyme activities of the original enzyme and mutants after treatment at different temperatures. DETAILED DESCRIPTION
[0018] The technical solution of the present invention is further described below in conjunction with the accompanying drawings.
[0019] Unless otherwise specified, the materials and reagents used in the examples can be obtained from commercial sources.
[0020] Example 1 Endoglucanase mutant V217L
[0021] In this example, Geobacillus sp. 70PC53 endoglucanase was used as the original enzyme, and the valine (V) at position 217 of the N-terminal amino acid sequence shown in SEQ ID No. 1 was mutated to leucine (L). The structure of the original enzyme is shown in Figure 1 As shown, the nucleic acid sequence is shown as SEQ ID No.2.
[0022] The preparation method of the mutant V217L is as follows: 1. constructing a recombinant plasmid; 2. expressing the enzyme mutant and preparing a crude enzyme solution.
[0023] The details are as follows:
[0024] 1. Construction of recombinant plasmid
[0025] Plasmid pET-22b(+) and E. coli DH5α were both commercially available and deposited by the applicant. The original enzyme was synthesized by Genwi (Suzhou) Co., Ltd. and inserted between the NdeI and XhoI restriction sites of plasmid pET-22b(+). 3D modeling was performed using PyMOL to determine that amino acid 217 was the mutation site. The position of this amino acid in the protein is as follows: Figure 1 Using the plasmid with the original enzyme as a template, site-directed mutagenesis was performed by PCR. The mutation primers are shown in Table 1, the PCR system is prepared as shown in Table 2, and the PCR program is set as shown in Table 3.
[0026] Table 1 V217L mutation primers
[0027] Mutation primer name Sequence (5'-3') V217L-F CGATCGCCTGGATGCGGCGCTGCAAGCGGGC V217L-R CGCATCCAGGCGATCGCGCAGCCACTGCGTATG
[0028] Note: The underlined part in the primers indicates the mutation site, “F” represents the upstream primer and “R” represents the downstream primer.
[0029] Table 2 PCR reaction system
[0030] Composition volume 10×BufferforKOD-Plus- 2.5μL 2mM dNTP 2.5μL <![CDATA[25mMMgSO4]]> 1.5μL DMSO 1μL 10pmol / μLForwardPrimer 0.75μL 10pmol / μLReversePrimer 0.75μL DNA template <100ng KOD-Plus- 1μL <![CDATA[ddH2O]]> up to 25 μL
[0031] Table 3 PCR reaction program
[0032]
[0033] 1 μL DpnI restriction endonuclease was added to the PCR product and digested at 37°C for 1 h.
[0034] 2. Construction of strains expressing recombinant mutant enzymes and preparation of crude enzyme solution
[0035] The above digestion products were transformed into E.coli DH5α competent cells by heat shock method, cultured at 37℃ for 1 hour, spread on LB solid medium containing 100μg / mL ampicillin, and cultured at 37℃ overnight. Select a single colony and inoculate it into LB liquid medium containing 100μg / mL ampicillin for overnight culture. Use the Sangon Plasmid Extraction Kit to extract the plasmid and send it to Jinweizhi (Suzhou) for sequencing. The plasmid with the correct mutant enzyme body was heat-shocked and transformed into E.coli BL21 competent cells, spread on LB solid medium containing 100μg / mL ampicillin, and cultured at 37℃ overnight. Select a single colony and inoculate it into LB liquid medium containing 100μg / mL ampicillin for overnight culture. Add 50% glycerol to the culture medium of the recombinant strain and store it at -80℃.
[0036] Pick the bacterial liquid from the glycerol bacteria and streak it on LB solid medium containing 100μg / mL ampicillin, and culture it at 37℃ overnight. Inoculate a single colony into 3mL LB liquid medium containing 100μg / mL ampicillin, and culture it at 37℃ for 8h. According to the 5% inoculation amount, it is transferred to a 250mL conical flask containing 50mL TB medium (yeast powder 12g / L, tryptone 12g / L, glycerol 4ml / L, dipotassium hydrogen phosphate 12.5g / L, potassium dihydrogen phosphate 2.3g / L), and cultured at 37℃ and 180rpm. After culturing for 8h, add 50μL 400mM IPTG solution and continue to culture at 22℃ for 22h. Collect the fermentation broth, centrifuge at 8000g for 20min, and collect the bacteria. Wash the cells twice with 200mM, pH7.0 PBS buffer, and finally resuspend the cells in 10mL of the corresponding pH buffer. The cells were disrupted by ultrasound for 5 minutes, and ultrasound was turned off for 5 seconds every 5 seconds. The mixture was centrifuged at 8000 g for 20 minutes, and the supernatant was collected as the crude enzyme solution of endoglucanase mutant V217L.
[0037] Example 2 Endoglucanase mutant N264Y
[0038] In this example, the asparagine (N) at position 264 of the N-terminal end of the original endoglucanase sequence shown in SEQ ID No. 1 is mutated to tyrosine (Y). The position of this amino acid in the protein is as follows Figure 2 The mutation primers are shown in Table 4. The preparation method is as shown in Example 1.
[0039] Table 4N264Y mutation primers
[0040] Mutation primer name Sequence (5'-3') N264Y-F GTTGGGTGTATTGGAGCCTGTGCGATAAAAAC N264Y-R GCTCCAATACACCCAACTAATGCCGCGTTC
[0041] Example 3 Endoglucanase mutant R170P / N264Y
[0042] In this example, the arginine (R) at position 170 of the N-terminal endoglucanase N264Y in Example 2 was mutated to proline (P). The position of this amino acid in the protein is as follows Figure 2 The primers are shown in Table 5. The preparation method is as shown in Example 2.
[0043] Table 5 Mutation primers
[0044] Mutation primer name Sequence (5'-3') R170P-F CATTGATCCGGATAACCTGATTATTGTGGGC R170P-R GGTTATCCGGATCAATGCTGCGAATGGTGCG
[0045] Example 4 Determination of the enzyme activity of the original endoglucanase and its mutants after treatment at different temperatures
[0046] Resuspend the cells in Examples 1 to 3 using Tris buffer with a pH value of 7.0, ultrasonically disrupt the cells as described in Example 1, and collect the crude enzyme solutions of the original enzyme and the three mutants. Seal the crude enzyme solution and divide it into 15 mL centrifuge tubes, and place it in a water bath at 65°C, 75°C, 85°C, and 95°C for 1 hour, respectively, and centrifuge to obtain the supernatant. Use 1% sodium carboxymethyl cellulose solution as the substrate for the enzymatic reaction, and use the dinitrosalicylic acid method to determine the residual enzyme activity. The specific method is: add 30 μL of crude enzyme solution and 120 μL of 1% sodium carboxymethyl cellulose solution to a clean ELISA plate, react at 60°C for 30 minutes, add 150 μL of DNS solution to stop the reaction and boil in water for 10 minutes, quickly cool to room temperature, and measure the absorbance at 540 nm. The sample to which the inactivated enzyme solution was added under the same conditions was used as a blank control. The enzyme activity (U) of endoglucanase is defined as: under the above reaction and analysis conditions, the amount of enzyme that catalyzes the production of 1 μmoL of glucose reducing power per minute is defined as one enzyme activity unit. The activity of the original enzyme at 65°C was defined as 100%, and the relative enzyme activity was calculated by comparing the activity of the remaining enzymes with that of the original enzyme at 65°C.
[0047] Test results such as Figure 3 As shown. The results showed that the enzyme activity of the original endoglucanase and the mutant enzyme decreased after being treated in an environment with a temperature above 65°C. After 1 hour in a 75°C water bath, the residual enzyme activity of the enzyme mutants V217L, N264Y and R170P / N264Y was higher than 50%. After 1 hour in a 85°C water bath, the residual enzyme activity of the enzyme mutant N264Y increased by 37.1% compared with the original enzyme. After 1 hour in a 95°C water bath, the residual enzyme activity of the enzyme mutant N264Y increased by 217.0% compared with the original enzyme.
Claims
1. An endoglucanase mutant, It is characterized in that The amino acid sequence of the endoglucanase mutant is obtained by mutation of the sequence shown in SEQ ID NO.1, and the mutation is V217L or N264Y or R170P / N264Y.
2. A nucleic acid molecule, It is characterized in that The nucleic acid molecule encodes the endoglucanase mutant according to claim 1.
3. The nucleic acid molecule according to claim 2, It is characterized in that The nucleotide sequence of the nucleic acid molecule is obtained by base mutation of the sequence shown in SEQ ID NO.
2.
4. A carrier, It is characterized in that Comprising the nucleotide sequence of claim 3.
5. The vector according to claim 4, It is characterized in that The vector is a cloning vector or an expression vector.
6. A recombinant cell, It is characterized in that The recombinant cell comprises the vector of claim 4.
7. A method for preparing the endoglucanase mutant according to claim 1, It is characterized in that The following steps are involved: (1) Designing point mutation primers, using a plasmid containing the nucleotide sequence of SEQ ID NO.2 as a template, performing a PCR reaction, digesting the template with an endonuclease, and then recombining the digestion product to obtain an expression vector carrying a mutant gene; (2) Transforming the expression vector into a host bacterium for fermentation expression; (3) Collecting the host bacterium, disrupting the cells, and centrifuging to obtain the supernatant to obtain the endoglucanase mutant.
8. A product, It is characterized in that The product comprises the endoglucanase mutant according to claim 1 or the nucleic acid molecule according to any one of claims 2 to 3 or the vector according to claim 4 or the recombinant cell according to claim 6.
9. Use of the product according to claim 8 in catalyzing cellulose hydrolysis.
10. The use according to claim 9, It is characterized in that The catalytic temperature is 65°C to 95°C.
Citation Information
Patent Citations
Endoglucanase NfE12A mutant with improved catalysis efficiency, and coding gene and application thereof
CN106566821A
Low-temperature beta-1, 4-endoglucanase and alkali-resistant enzyme mutant
CN116497006A
Endo-beta-1, 4-glucanase mutant as well as gene, carrier and preparation method thereof
CN118165960A
Novel Thermophilic Endo-Glucanase and Uses Thereof
US20100047869A1
Cited By
Endoglucanase mutant, coding gene, vector, engineering bacterium and application thereof
CN122038357A
